Article
New Plaques Arising at Site of Previously Excised Basal Cell Carcinoma
A 79-year-old man presented to dermatology with an enlarging bump on the right cheek. He reported a history of basal cell carcinoma on the medial...
News
ISCHEMIA-CKD: No benefit for coronary revascularization in advanced CKD with stable angina
PHILADELPHIA – At 3 years, more than 27% of patients were dead regardless of the coronary artery disease management strategy.
News
IL-1 alpha is a new target in atopic dermatitis
MADRID – Bermekimab shows encouraging results in atopic dermatitis proof-of-concept study.
News
Cannabis frequently is used for endometriosis pain
VANCOUVER, B.C. – Survey finds more than a third of patients have used marijuana or CBD, and some find it effective...
Article
OTC hormonal contraception: An important goal in the fight for reproductive justice
Access to contraception is not equal. This is especially true in states with a shortage of health care providers and barriers to adequate...
News
Open enrollment 2020: Activity down on Healthcare.gov
Consumers choose fewer plans during week 3, compared with last week and last year.
Opinion
Newer IL-17 inhibitors make their case in phase 3 nonradiographic axial spondyloarthritis trials
There appears to be very little to favor either ixekizumab or secukinumab over the other.
News
FDA approves Givlaari for treatment of acute hepatic porphyria
Prior to this approval, existing treatments provided only partial relief from porphyria attacks, according to the FDA.
News
COAST-X top-line results: Ixekizumab improves nonradiographic axSpA vs. placebo
ATLANTA – Adding ixekizumab to conventional background medications significantly improved the signs and symptoms of nonradiographic axSpA in the...
News
Dealing with off-label medical device use in vascular surgery